Oral Prednisolone to Prevent Esophageal Stricture After RFA for Long-segment Esophageal Neoplasia
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
Endoscopic radiofrequency ablation (RFA) has shown good efficacy and safety in eradicating
flat-type early esophageal squamous cell neoplasia (ESCN). However, post-RFA stricture is
still a major concern, especially when treating long-segment early ESCNs. The aim of this
study was to investigate the efficacy and safety of oral prednisolone to prevent post-RFA
stricture.